Ticker Details
Inhibrx, Inc.
IPO Date:	August 19, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.14B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.91 | 3.45%
Avg Daily Range (30 D):	$2.61 | 3.37%
Avg Daily Range (90 D):	$2.72 | 3.89%

Institutional Daily Volume
Avg Daily Volume:	.25M
Avg Daily Volume (30 D):	.14M
Avg Daily Volume (90 D):	.29M

Trade Size
Avg Trade Size (Sh.):	63
Avg Trade Size (Sh.) (30 D):	40
Avg Trade Size (Sh.) (90 D):	44

Institutional Trades
Total Institutional Trades:	1,352
Avg Institutional Trade:	$2.22M
Avg Institutional Trade (30 D):	$2.34M
Avg Institutional Trade (90 D):	$2.51M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.15M
Avg Closing Trade (30 D):	$1.44M
Avg Closing Trade (90 D):	$2.08M
Avg Closing Volume:	76.5K

News

Oct 24, 2025 @ 5:22 PM Stocks Soar To Records After Weak Inflation, Ford ... Source: Piero Cingari

Oct 24, 2025 @ 7:05 AM Why Are Inhibrx Biosciences Shares Soaring 76% Aft... Source: Mohd Haider

Jul 23, 2024 @ 9:01 AM Inhibrx stock rated 'Market Perform' by JMP after ... Source: Emilio Ghigini

Feb 28, 2024 @ 3:25 PM Inhibrx, Inc. (INBX) Reports Q4 Loss, Tops Revenue... Source: Zacks Equity Research

Feb 22, 2024 @ 10:15 PM BioMarin Pharmaceutical (BMRN) Beats Q4 Earnings a... Source: Zacks Equity Research

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-11.96	$-2.28
Diluted EPS	$-11.4	$-2.28
Revenue	$1.4M	$M
Gross Profit
Net Income / Loss	$-155.09M	$-35.26M	$-28.65M
Operating Income / Loss	$-154.03M	$-33.81M
Cost of Revenue
Net Cash Flow	$-43.24M
PE Ratio